Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 May;64(5):1614–1620. doi: 10.1128/iai.64.5.1614-1620.1996

Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells.

C A Gaydos 1, J T Summersgill 1, N N Sahney 1, J A Ramirez 1, T C Quinn 1
PMCID: PMC173970  PMID: 8613369

Abstract

Chlamydia pneumoniae has recently been associated with atherosclerotic lesions in coronary arteries. To investigate the biological basis for the dissemination and proliferation of this organism in such lesions, the in vitro growth of C. pneumoniae was studied in two macrophage cell lines, peripheral blood monocyte-derived macrophages, human bronchoalveolar lavage macrophages, several endothelial cell lines, and aortic smooth muscle cells. Five strains of C. pneumoniae were capable of three passages in human U937 macrophages and in murine RAW 246.7 macrophages. Titers were suppressed in both macrophage types with each passage, as compared with growth titers in HEp-2 cells. Both human bronchoalveolar lavage macrophages and peripheral blood monocyte-derived macrophages were able to inhibit C. pneumoniae after 96 h of growth. Eleven C. pneumoniae strains were capable of replicating in normal human aortic artery-derived endothelial cells, umbilical vein-derived endothelial cells, and pulmonary artery endothelial cells. Infection in human aortic artery smooth muscle cells was also established for 13 strains of C. pneumoniae. The in vitro ability of C. pneumoniae to maintain infections in macrophages, endothelial cells, and aortic smooth muscle cells may provide support for the hypothesis that C. pneumoniae can infect such cells and, when infection is followed by an immune response, may contribute to atheroma formation in vivo. More studies are needed to investigate the complex relationship between lytic infection and persistence and the potential for C. pneumoniae to influence the generation of atheromatous lesions.

Full Text

The Full Text of this article is available as a PDF (425.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Augenbraun M. H., Roblin P. M., Chirgwin K., Landman D., Hammerschlag M. R. Isolation of Chlamydia pneumoniae from the lungs of patients infected with the human immunodeficiency virus. J Clin Microbiol. 1991 Feb;29(2):401–402. doi: 10.1128/jcm.29.2.401-402.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chirgwin K., Roblin P. M., Gelling M., Hammerschlag M. R., Schachter J. Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis. 1991 Apr;163(4):757–761. doi: 10.1093/infdis/163.4.757. [DOI] [PubMed] [Google Scholar]
  3. Emre U., Roblin P. M., Gelling M., Dumornay W., Rao M., Hammerschlag M. R., Schachter J. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med. 1994 Jul;148(7):727–732. doi: 10.1001/archpedi.1994.02170070065013. [DOI] [PubMed] [Google Scholar]
  4. Fang G. D., Fine M., Orloff J., Arisumi D., Yu V. L., Kapoor W., Grayston J. T., Wang S. P., Kohler R., Muder R. R. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1990 Sep;69(5):307–316. doi: 10.1097/00005792-199009000-00004. [DOI] [PubMed] [Google Scholar]
  5. Freeman A. P., Freeman Z. S. Chlamydia endocarditis. Med J Aust. 1981 Jun 13;1(12):642–642. [PubMed] [Google Scholar]
  6. Gaydos C. A., Eiden J. J., Oldach D., Mundy L. M., Auwaerter P., Warner M. L., Vance E., Burton A. A., Quinn T. C. Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay. Clin Infect Dis. 1994 Jul;19(1):157–160. doi: 10.1093/clinids/19.1.157. [DOI] [PubMed] [Google Scholar]
  7. Gaydos C. A., Fowler C. L., Gill V. J., Eiden J. J., Quinn T. C. Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in an immunocompromised population. Clin Infect Dis. 1993 Oct;17(4):718–723. doi: 10.1093/clinids/17.4.718. [DOI] [PubMed] [Google Scholar]
  8. Gaydos C. A., Quinn T. C., Bobo L. D., Eiden J. J. Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene. Infect Immun. 1992 Dec;60(12):5319–5323. doi: 10.1128/iai.60.12.5319-5323.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gnarpe J., Gnarpe H., Sundelöf B. Endemic prevalence of Chlamydia pneumoniae in subjectively healthy persons. Scand J Infect Dis. 1991;23(3):387–388. doi: 10.3109/00365549109024328. [DOI] [PubMed] [Google Scholar]
  10. Grayston J. T., Aldous M. B., Easton A., Wang S. P., Kuo C. C., Campbell L. A., Altman J. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis. 1993 Nov;168(5):1231–1235. doi: 10.1093/infdis/168.5.1231. [DOI] [PubMed] [Google Scholar]
  11. Grayston J. T., Campbell L. A., Kuo C. C., Mordhorst C. H., Saikku P., Thom D. H., Wang S. P. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990 Apr;161(4):618–625. doi: 10.1093/infdis/161.4.618. [DOI] [PubMed] [Google Scholar]
  12. Grayston J. T., Diwan V. K., Cooney M., Wang S. P. Community- and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically. Arch Intern Med. 1989 Jan;149(1):169–173. [PubMed] [Google Scholar]
  13. Grayston J. T. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis. 1992 Nov;15(5):757–761. doi: 10.1093/clind/15.5.757. [DOI] [PubMed] [Google Scholar]
  14. Hahn D. L., Dodge R. W., Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA. 1991 Jul 10;266(2):225–230. [PubMed] [Google Scholar]
  15. Haidl S., Ivarsson S., Bjerre I., Persson K. Guillain-Barré syndrome after Chlamydia pneumoniae infection. N Engl J Med. 1992 Feb 20;326(8):576–577. [PubMed] [Google Scholar]
  16. Hammerschlag M. R., Chirgwin K., Roblin P. M., Gelling M., Dumornay W., Mandel L., Smith P., Schachter J. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis. 1992 Jan;14(1):178–182. doi: 10.1093/clinids/14.1.178. [DOI] [PubMed] [Google Scholar]
  17. Holland S. M., Taylor H. R., Gaydos C. A., Kappus E. W., Quinn T. C. Experimental infection with Chlamydia pneumoniae in nonhuman primates. Infect Immun. 1990 Mar;58(3):593–597. doi: 10.1128/iai.58.3.593-597.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hyman C. L., Augenbraun M. H., Roblin P. M., Schachter J., Hammerschlag M. R. Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR. J Clin Microbiol. 1991 Sep;29(9):2082–2083. doi: 10.1128/jcm.29.9.2082-2083.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hyman C. L., Roblin P. M., Gaydos C. A., Quinn T. C., Schachter J., Hammerschlag M. R. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis. 1995 May;20(5):1174–1178. doi: 10.1093/clinids/20.5.1174. [DOI] [PubMed] [Google Scholar]
  20. Jones R. B., Priest J. B., Kuo C. Subacute chlamydial endocarditis. JAMA. 1982 Feb 5;247(5):655–658. [PubMed] [Google Scholar]
  21. Kaukoranta-Tolvanen S. S., Laitinen K., Saikku P., Leinonen M. Chlamydia pneumoniae multiplies in human endothelial cells in vitro. Microb Pathog. 1994 Apr;16(4):313–319. doi: 10.1006/mpat.1994.1032. [DOI] [PubMed] [Google Scholar]
  22. Kuo C. C., Shor A., Campbell L. A., Fukushi H., Patton D. L., Grayston J. T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993 Apr;167(4):841–849. doi: 10.1093/infdis/167.4.841. [DOI] [PubMed] [Google Scholar]
  23. Marrie T. J., Grayston J. T., Wang S. P., Kuo C. C. Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med. 1987 Apr;106(4):507–511. doi: 10.7326/0003-4819-106-4-507. [DOI] [PubMed] [Google Scholar]
  24. Marrie T. J., Harczy M., Mann O. E., Landymore R. W., Raza A., Wang S. P., Grayston J. T. Culture-negative endocarditis probably due to Chlamydia pneumoniae. J Infect Dis. 1990 Jan;161(1):127–129. doi: 10.1093/infdis/161.1.127. [DOI] [PubMed] [Google Scholar]
  25. Miller S. T., Hammerschlag M. R., Chirgwin K., Rao S. P., Roblin P., Gelling M., Stilerman T., Schachter J., Cassell G. Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease. J Pediatr. 1991 Jan;118(1):30–33. doi: 10.1016/s0022-3476(05)81839-6. [DOI] [PubMed] [Google Scholar]
  26. Ogawa H., Fujisawa T., Kazuyama Y. Isolation of Chlamydia pneumoniae from middle ear aspirates of otitis media with effusion: a case report. J Infect Dis. 1990 Oct;162(4):1000–1001. doi: 10.1093/infdis/162.4.1000. [DOI] [PubMed] [Google Scholar]
  27. Rothermel C. D., Schachter J., Lavrich P., Lipsitz E. C., Francus T. Chlamydia trachomatis-induced production of interleukin-1 by human monocytes. Infect Immun. 1989 Sep;57(9):2705–2711. doi: 10.1128/iai.57.9.2705-2711.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Saikku P., Leinonen M., Mattila K., Ekman M. R., Nieminen M. S., Mäkelä P. H., Huttunen J. K., Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988 Oct 29;2(8618):983–986. doi: 10.1016/s0140-6736(88)90741-6. [DOI] [PubMed] [Google Scholar]
  29. Saikku P., Leinonen M., Tenkanen L., Linnanmäki E., Ekman M. R., Manninen V., Mänttäri M., Frick M. H., Huttunen J. K. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992 Feb 15;116(4):273–278. doi: 10.7326/0003-4819-116-4-273. [DOI] [PubMed] [Google Scholar]
  30. Shapiro D. S., Kenney S. C., Johnson M., Davis C. H., Knight S. T., Wyrick P. B. Brief report: Chlamydia psittaci endocarditis diagnosed by blood culture. N Engl J Med. 1992 Apr 30;326(18):1192–1195. doi: 10.1056/NEJM199204303261805. [DOI] [PubMed] [Google Scholar]
  31. Shor A., Kuo C. C., Patton D. L. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J. 1992 Sep;82(3):158–161. [PubMed] [Google Scholar]
  32. Thom D. H., Wang S. P., Grayston J. T., Siscovick D. S., Stewart D. K., Kronmal R. A., Weiss N. S. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb. 1991 May-Jun;11(3):547–551. doi: 10.1161/01.atv.11.3.547. [DOI] [PubMed] [Google Scholar]
  33. Ward C., Sagar H. J., Cooper D., Ward A. M. Insidious endocarditis caused by Chlamydia psittaci. Br Med J. 1975 Dec 27;4(5999):734–735. doi: 10.1136/bmj.4.5999.734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wyrick P. B., Brownridge E. A. Growth of Chlamydia psittaci in macrophages. Infect Immun. 1978 Mar;19(3):1054–1060. doi: 10.1128/iai.19.3.1054-1060.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. van der Bel-Kahn J. M., Watanakunakorn C., Menefee M. G., Long H. D., Dicter R. Chlamydia trachomatis endocarditis. Am Heart J. 1978 May;95(5):627–636. doi: 10.1016/0002-8703(78)90305-8. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES